“a decreasing trend”

Rumen Fermentation Parameters As shown in Figure 2 , compared to RTW, the concentrations of acetate ( p = 0.04), propionate ( p < 0.01), isobutyrate ( p = 0.02), and T-VFAs ( p < 0.01) in the rumen fluid of HW significantly increased, while the ratio of acetate to propionate showed a decreasing trend ( p = 0.06) of HW. 3.3.

Consistently, targeted LC-MS analysis revealed a decreasing trend in luminal serotonin levels in the KC84-treated group ( p = 0.06; Fig. 3 C).

In-hospital mortality was 48.0% overall, with a decreasing trend during the study period that approached statistical significance (p=0.06).

There was a decreasing trend in total distress from pre-trip to post-trip ( t (37.04) = −1.89, p = 0.06), with levels of total distress at the 3-month follow-up remaining substantially below pre-trip levels, although the decrease from baseline to the 3 month follow-up was not significant ( P = .54).

There was a decreasing trend in IL-22 mRNA expression in the jejunum after SB administration ( p = 0.06).

In contrast, the expression level of arginase-1, an M2-type microglial marker, was significantly reduced in OBX mice, while TGF-β exhibited a decreasing trend that did not reach statistical significance ( p = 0.06; Fig. 4 J and K).

5A is also an increasing trend for sialylated structures in cancerous tissue ( p = 0.1) and a decreasing trend for fucosylated structures and H type epitope containing structures ( p = 0.06 and p = 0.10, respectively).

There was no significant difference in the nNOS levels in the cecum, but a decreasing trend was observed in the colon (p=0.06).

Q21, Q25 and QA85 resulted in a decreasing trend of H. pylori load in volunteers (454.30 ± 327.00 vs. 328.35 ± 237.19, p = 0.06).

Moreover, there was also a decreasing trend in glucose levels at OGTT time T60 for the PPEP group compared with the control group ( p = 0.06).

Furthermore, 7 keto-cholesterol, which can be formed from cholesterol via autoxidation [ 28 ] or from 7-DHC via CYP7A1 [ 29 , 30 ], showed a decreasing trend with cholic acid treatment, particularly for patients with a high baseline level ( p = 0.06).

A decreasing trend of PARP-1 level was observed in the S100B I group (0.8 ± 0.3 units) compared to the PBS group (1.8 ± 0.2 units, p = 0.06; Figure 2E ).

0%, p = 0.05) in period 2, and we noted a decreasing trend in treatment failures (0% vs. 8.1%, p = 0.06) ( Table 1 ). 4.

The TEWL showed a decreasing trend following treatment with EVOO (9.56 g·m −2 ·h −1 vs. 8.52 g·m −2 ·h −1 , p = 0.06) and a significant decrease with petrolatum (9.56 g·m −2 ·h −1 vs. 8.18 g·m −2 ·h −1 , p = 0.016).

Levels of inosine in preoperative CSF also exhibited a decreasing trend in POD patients (FC POD/Non-POD = 0.82, p = 0.06), partially reflecting the enhanced oxidative damage to cell nuclei and mitochondrial DNA.

However, when the CVID group was analyzed, we observed a reduction in the frequency of CD69+CD137+CD4+T cells (p = 0.02), and a decreasing trend in both CD69+CD154+CD4+ (p = 0.06) and CD25+OX40+CD4+T cells (p = 0.08) from w8 to w24 ( Figures 5 A–5C).

A decreasing trend was observed in plateletcrit (PCT; p = 0.0600) and eosinophil percentage (EOS, p = 0.0880), whereas the LUC ( p = 0.0656) showed an increasing trend ( Table 3 ).

MG velocity gain (p = 0.004*) decreased, and displacement gain had a decreasing trend (p = 0.06) that was not statistically significant ( Figure 9 , Reversal).

The hospital mortality showed a decreasing trend (18%, P = 0.06).

Although no statistically significant differences were observed ( Figure 3 B, C, D ), the rate of change in creatinine, a marker of damage, showed a decreasing trend in MA condition after the intervention ( Figure 3 D, P = 0.06).

In addition, it showed a decreasing trend in Verrucomicrobia ( p = 0.06) in OS vs.

As shown in Table 1 although the average methylation rates of the Fas promoter were not changed after nicotine treatment, among those CpG sites, nt +295, −2394, and −2441 showed significantly decreased frequency of single CpG methylation after nicotine treatment ( P < 0.05), and the methylation level on nt +456 also showed a decreasing trend ( P = 0.06).

A decreasing trend was shown in patients with each factor (22.2% vs. 52.9%, P = 0.0601; 11.1% vs. 29.4%, P = 0.1761, respectively) in the smoking cessation group compared with the smoking group, although each factor has been reported to be lower in those who could quit smoking.

The prevalence of hypertension also showed a decreasing trend from 47.0% to 37.0% ( p = 0.0601) in males, and a significant decrease from 26.5% to 19.8% ( p = 0.0102) in females. 3.4.

Additionally, ALT/AST ratio, ALB, and TAA levels were significantly higher in the HSTG group ( P < 0.05), with ALT showing an increasing trend ( P = 0.061) and AST showing a decreasing trend ( P = 0.062).